Home > Boards > Free Zone > All Fundamentals > $Pistol Pete$, $Mick$ & Friends Stock Picks /news, DD and charts

$CANB ...NEWS JUST OUT!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (12) | Next 10 | Previous | Next
TommyBoyTrader9460 Member Profile
Member Level 
Followed By 1,867
Posts 49,064
Boards Moderated 7
Alias Born 06/06/12
160x600 placeholder
Top Company News of the Day
The FDA's authorization expands the drug's use to fight Covid-19 to people under the age of 12.
Soybeans Futures Higher on Export Hopes - Daily Grain Highlights
FDA Expands Emergency Use for Lilly Antibody Combination for Covid-19 to Include Infants
Front Month Nymex Natural Gas Fell 24.56% This Week to Settle at $4.1320 -- Data Talk
Front Month Nymex RBOB Gasoline Fell 1.42% This Week to Settle at $1.9529 -- Data Talk
Merck in Supply Agreement With Canada for Antiviral Medicine for Covid-19
Trade Deficit, Consumer Prices on Deck -- Data Week Ahead
Sportsman's Warehouse Shares Fall 19% After Takeover Deal Terminated
EURO STOXX 50 Index Ends the Week 0.23% Lower at 4080.15 -- Data Talk
FTSE 100 Index Ends the Week 1.11% Higher at 7122.32 -- Data Talk
DAX Ends the Week 0.57% Lower at 15169.98 -- Data Talk
CAC 40 Index Ends the Week 0.38% Higher at 6765.52 -- Data Talk
STOXX Europe 50 Index Ends the Week 0.20% Higher at 3613.81 -- Data Talk
STOXX Europe 600 Index Ends the Week 0.28% Lower at 462.77 -- Data Talk
FTSE Closes Down Amid Persistent Growth Fears
Roche to Name New Member to Board of Directors, Re-Elect Chairman
Adobe Down Over 6%, On Pace for Largest Percent Decrease Since March 2020 -- Data Talk
U.S. Services Sector Growth Accelerated to New Record-High in November -- ISM
U.S. Services Sector Growth Cooled Slightly in November -- IHS Markit
FTSE Edges Higher, Wickes's Margin Outperformance Leads to Further Upgrades
U.S. Nonfarm Payrolls Up 210K in November, Unemployment Rate 4.2% -- Update
Johnson & Johnson's Janssen Says Psoriatic Arthritis Trial Meets Objective
Bostic Wants to Speed Up Fed's Asset Buying Taper; Quarles Says Fed Will Need to Raise Rates
U.S. Nonfarm Payrolls Up 210K in November, Unemployment Rate 4.2%
Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
FTSE Edges Higher, Service Sector Kept Growth Momentum in November
TommyBoyTrader9460 Member Level  Thursday, 12/17/20 09:12:03 AM
Re: mick post# 227175
Post # of 237012 
$CANB ...NEWS JUST OUT!

Can B Corp Closes $2.8 Million New Financing
6:00 AM ET 12/17/20 | Dow Jones
Related Quotes


3:59 PM ET 12/16/20
Symbol Last % Chg
CANB
0.45 0.00%
Real time quote.


Can B Corp Closes $2.8 Million New Financing

Eliminates All Prior Existing Convertible Debt and Provides Growth Capital

HICKSVILLE, NY, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp. (OTCQB: CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce the closing of a $2.8 million debt financing from an institutional investor.

The investment enables Can B to pay off and eliminate all prior outstanding convertible notes without penalty. In addition, the new investment, along with an ongoing Reg A offering, should provide the capital needed to return to growth in 2021. Please see the Company's recently filed 8K https://tinyurl.com/ycw5muor for complete details of the new debt financing.

As Can B closes the year of the COVID and starts fresh in 2021 with a feeling of optimism with all of the company's operating divisions trending upward. The Company's actions over the last year have led to development of a vertically integrated platform for controlling its products from seed to sale with a multi-prong channel strategy in bringing health and wellness to consumers. Pure Health Products is gearing up for an intended GMP certification in the first quarter of 2021, a path Company believes, that every CBD manufacturer will be required to meet in the future. Pure Health Products is also securing additional new white label customers as well as adding to its own branded line of products. Additionally, Duramed has expanded its no-fault insurance products and service availability to the state of Michigan and has added with new medical devices to its portfolio.

Marco Alfonsi, Can B's Chief Executive Officer, commented, "This transaction marks a significant milestone for the Company as we were able to pay off and eliminate all prior existing convertible notes to avoid default and in addition to have the capital needed to return to growth in 2021. We look forward to continuing to build value for all of our shareholders."

About Can B Corp.

Can B Corp. (OTCQB: CANB) is a Health & Wellness company providing the highest quality cannabidiol (CBD) products under the brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B is also an exclusive partner of the LifeGuard(R) Brand in developing a line of consumer products. The Company is also launching Super Foods, a line of nutritional supplements. Can B Corp. owns and operates an R&D and production facility in Lacey, WA, and Green Grow Farms, a licensed hemp grow and cultivation in New York. To learn more about Can B Corp. and our comprehensive line of high-quality CBD products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.

For more information about Can B Corp., please visit: CanBCorp.com

Twitter @CanBCorp

Instagram @canbcorp

Facebook @ Can B Corp

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape, or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Investors and Media:

IR@canbiola.com

(917) 658-7878

> Dow Jones Newswires

December 17, 2020 06:00 ET (11:00 GMT)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (12) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences